Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in youngsters and grown-ups . In Canada, its distribution is overseen by Health https://apolisdexamfetamineforsa700137.bloggingvalley.com/61720102/this-medication-in-canada-a-comprehensive-guide